Geron (GERN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Geron (GERN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: (no name provided) who wrote (15)	2/24/1997 3:56:00 PM
From: louis mason	of 50

Cloning a telomerase homolog Has anybody seen the news that three scientists at Amgen, Inc. (along with the U. of Toronto) have cloned a mammalian telomerse homolog named TP1? I wasn't aware of any Amgen-Geron collaborations, so are they potential competitors? This cloning alone may not change any "balances-of-power" in the telomerase arena, but does it suggest the interest of Amgen in this field? TP1 may be one of two components that constitute a telomerase machine- so cloning & overexpressing this enzyme could greatly help any companies screening program. What do the people on this thread think? Neutral or Good news for Amgen? Bad news for anybody else? Or couldn't the investors care less about the science? louis mason

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next